Semmelweis University is constantly monitoring the international and domestic situation of the novel coronavirus (SARS-CoV-2) and is taking necessary measures within the university. A Semmelweis Epidemiological Operational Board was set up by the Rector in order to most efficiently carry out the necessary steps. If you have not found the professional answer to your question, please contact firstname.lastname@example.org and our colleagues will get back to you withing 24 hours.
First patient with Paediatric Inflammatory Multisystem Syndrome diagnosed at Semmelweis University
2020. November 27.
The 2-year-old boy has been released from hospital after recovering from coronavirus infection related complication.
Dr. Béla Merkely talked about the role of Semmelweis University in the fight against coronavirus
2020. November 17.
The aim of the virtual event was to reflect on those new situations that higher education has to face because of COVID-19.
2020. November 17.
Dr. Béla Merkely, Rector of Semmelweis University is currently in quarantine.
Semmelweis students can take part in the fight against coronavirus in the framework of an elective course
2020. November 16.
The new elective course enables the students to receive credit points for their participation in PCR testing and other medical procedures.
Dr. Béla Merkely asks for a cooperative attitude from the people
2020. November 12.
Dr. Béla Merkely talked about the recently introduced package of restrictive measures in an interview he conducted on M1 News.
The Ministry of Innovation and Technology expressed its gratitude to Semmelweis University in a video message
2020. November 9.
The Ministry for Innovation and Technology expressed its gratitude to the health care professionals of Semmelweis University.
New Hungarian patent may be a promising treatment for COVID-19 complications
2020. November 6.
A breakthrough in the treatment of pneumonia and its complications caused by COVID-19, led by Dr. Andrea Fekete.
Rector’s notice (updated)
2020. November 2.
Dr. Béla Merkely, rector's notice to the students of Semmelweis University in order to participate in the testing procedures.
The first patient treated with Hungarian remdesivir released from Semmelweis clinic
2020. October 26.
The 75-year-old COVID-19 patient was the first to be treated with the Hungarian remdesivir at Semmelweis University.
“I wanted to play my part in the fight against the virus” – nearly 200 students involved in PCR testing
2020. October 22.
Some wanted to get hands-on experience and others wanted to contribute to the fight against the epidemic.
Clinical research results on the use of remdesivir in COVID-19 patients
2020. October 20.
The use of remdesivir seems to be the most effective if used as part of a combination therapy of plasma rich in COVID-antibody, steroids …
Hungarian remdesivir is already in use at three clinics of Semmelweis University
2020. October 19.
Seven COVID-19 patients have already been treated with the Hungarian remdesivir at Semmelweis University.
Semmelweis University inaugurates renovated student spaces and applauds volunteers
2020. October 8.
The new and modenr courtyard at the Department of Anatomy, Histology and Embriology was inaugurated.
Semmelweis University participates in testing a newer, simpler single-step PCR test
2020. October 7.
The test developed by Hungarian-owned Omixon Biocomputing Ltd. will be used in increasing numbers.